The adaptation period can last weeks to months, during which skin may look worse before improving
Category 1 status means a compound is eligible for use by licensed compounding pharmacies to prepare individualized medications under a physician's prescription
Its mechanism is based on increasing the expression of neurotrophic factors such as BDNF (Brain-Derived Neurotrophic Factor), which translates into: DIHEXA was developed by scientists at Washington State University as a potential therapeutic agent, originally studied for the treatment of neurodegenerative diseases such as Alzheimer's and Parkinson's
Dysmenorrhea, painful intercourse, painful bowel movements, bloating (often called "endo belly"), fatigue, and depression and anxiety are all part of the picture
They could also cut the replication of viral cells, reducing the severity of COVID-19